Modafinil-induced reversible hyperkinetic nondystonic movement disorder in a patient with major depressive disorder.
Luborzewski
Alexander
A
Regen
Francesca
F
Schindler
Frank
F
Anghelescu
Ion
I
D000368:Aged; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000009:adverse effects; D001559:Benzhydryl Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000009:adverse effects*; D003511:Cyclohexanols / Q000008:administration & dosage / Q000009:adverse effects; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced* / Q000175:diagnosis; D000077408:Modafinil; D009460:Neurologic Examination / Q000187:drug effects; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride; D000077408:Modafinil